378 related articles for article (PubMed ID: 24764299)
1. Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis.
Halpert G; Eitan T; Voronov E; Apte RN; Rath-Wolfson L; Albeck M; Kalechman Y; Sredni B
J Biol Chem; 2014 Jun; 289(24):17215-27. PubMed ID: 24764299
[TBL] [Abstract][Full Text] [Related]
2. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
Kalechman Y; Gafter U; Gal R; Rushkin G; Yan D; Albeck M; Sredni B
J Immunol; 2002 Jul; 169(1):384-92. PubMed ID: 12077268
[TBL] [Abstract][Full Text] [Related]
3. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
4. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
Brodsky M; Yosef S; Galit R; Albeck M; Longo DL; Albeck A; Sredni B
J Interferon Cytokine Res; 2007 Jun; 27(6):453-62. PubMed ID: 17572009
[TBL] [Abstract][Full Text] [Related]
5. Glial-derived neurotrophic factor reduces inflammation and improves delayed colonic transit in rat models of dextran sulfate sodium-induced colitis.
Liu GX; Yang YX; Yan J; Zhang T; Zou YP; Huang XL; Gan HT
Int Immunopharmacol; 2014 Mar; 19(1):145-52. PubMed ID: 24462388
[TBL] [Abstract][Full Text] [Related]
6. Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
Matos I; Bento AF; Marcon R; Claudino RF; Calixto JB
Mol Immunol; 2013 Jul; 54(3-4):482-92. PubMed ID: 23454360
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
Kalechman Y; Sredni B
J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
[TBL] [Abstract][Full Text] [Related]
8. Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway.
Vishwakarma P; Parmar N; Chandrakar P; Sharma T; Kathuria M; Agnihotri PK; Siddiqi MI; Mitra K; Kar S
Cell Mol Life Sci; 2018 Feb; 75(3):563-588. PubMed ID: 28900667
[TBL] [Abstract][Full Text] [Related]
9. Tellurium Compounds Prevent and Reverse Type-1 Diabetes in NOD Mice by Modulating α4β7 Integrin Activity, IL-1β, and T Regulatory Cells.
Yossipof TE; Bazak ZR; Kenigsbuch-Sredni D; Caspi RR; Kalechman Y; Sredni B
Front Immunol; 2019; 10():979. PubMed ID: 31191514
[TBL] [Abstract][Full Text] [Related]
10. Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways.
Lee H; Son YS; Lee MO; Ryu JW; Park K; Kwon O; Jung KB; Kim K; Ryu TY; Baek A; Kim J; Jung CR; Ryu CM; Park YJ; Han TS; Kim DS; Cho HS; Son MY
Theranostics; 2020; 10(11):5048-5063. PubMed ID: 32308767
[TBL] [Abstract][Full Text] [Related]
11. The effect of the novel tellurium compound AS101 on autoimmune diseases.
Halpert G; Sredni B
Autoimmun Rev; 2014 Dec; 13(12):1230-5. PubMed ID: 25153485
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis.
Xia XM; Wang FY; Xu WA; Wang ZK; Liu J; Lu YK; Jin XX; Lu H; Shen YZ
World J Gastroenterol; 2010 Jun; 16(23):2873-80. PubMed ID: 20556832
[TBL] [Abstract][Full Text] [Related]
13. The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis.
Xie L; Chen J; McMickle A; Awar N; Nady S; Sredni B; Drew PD; Yu S
J Neuroimmunol; 2014 Aug; 273(1-2):31-41. PubMed ID: 24975323
[TBL] [Abstract][Full Text] [Related]
14. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
15. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
16. The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.
Halpert G; Halperin Sheinfeld M; Monteran L; Sharif K; Volkov A; Nadler R; Schlesinger A; Barshak I; Kalechman Y; Blank M; Shoenfeld Y; Amital H
Clin Exp Immunol; 2021 Mar; 203(3):375-384. PubMed ID: 33205391
[TBL] [Abstract][Full Text] [Related]
17. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.
Sredni B; Tichler T; Shani A; Catane R; Kaufman B; Strassmann G; Albeck M; Kalechman Y
J Natl Cancer Inst; 1996 Sep; 88(18):1276-84. PubMed ID: 8797767
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice.
Salas A; Gironella M; Salas A; Soriano A; Sans M; Iovanna J; Piqué JM; Panés J
Lab Invest; 2002 May; 82(5):597-607. PubMed ID: 12004000
[TBL] [Abstract][Full Text] [Related]
20. β7-Integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon.
Schippers A; Muschaweck M; Clahsen T; Tautorat S; Grieb L; Tenbrock K; Gaßler N; Wagner N
Mucosal Immunol; 2016 Mar; 9(2):527-38. PubMed ID: 26349655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
